Tandem Labs, established in 1981, is a leading bioanalytical and immunoanalytical contract research organization catering to the pharmaceuticals and biotechnology industries in the United States. With expertise in advanced mass spectrometry and pharmacokinetics, the organization offers comprehensive support for discovery, preclinical, and clinical drug development programs. Tandem Labs operates facilities in Utah, New Jersey, and Massachusetts and is licensed to handle radioactive materials. Its services include dose formulation analysis, method development and validation, cell-based and immunogenicity assays, and drug metabolite profiling. As a part of Laboratory Corporation of America Holdings, Tandem Labs is committed to delivering high-quality solutions to its clients.
Show More